(SKWD) Skyward Specialty Insurance - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US8309401029
SKWD EPS (Earnings per Share)
SKWD Revenue
SKWD: Liability, Commercial Auto, Property, Workers Compensation, Surety
Skyward Specialty Insurance Group, Inc. is a US-based insurance holding company specializing in commercial property and casualty insurance products. The company offers a diverse range of insurance products, including general liability, excess liability, and workers compensation insurance, as well as niche products like cannabis insurance. With its headquarters in Houston, Texas, Skyward Specialty Insurance Group has established itself as a significant player in the US insurance market.
From a business perspective, Skyward Specialty Insurance Groups diverse product offerings and focus on specialty insurance lines position it well for growth in a hardening insurance market. The companys ability to underwrite a range of commercial property and casualty insurance products allows it to capitalize on opportunities in various sectors, including emerging industries like cannabis. As the insurance landscape continues to evolve, Skyward Specialty Insurance Groups adaptability and expertise in specialty insurance lines are likely to drive its success.
Analyzing the
Based on the available data, our forecast suggests that Skyward Specialty Insurance Groups stock is likely to continue its upward trend, driven by the companys strong fundamentals and favorable market conditions. With a RoE of 15.68%, the company is demonstrating a robust ability to generate returns on equity. As the stock price is currently above its SMA200, we expect it to continue to trend upwards, potentially reaching the 52-week high of $65.00 in the near term. However, investors should be cautious of potential volatility, as indicated by the ATR of 2.01, equivalent to 3.36%. A buy-and-hold strategy with a medium-term horizon appears to be a viable approach, given the companys strong financials and growth prospects.
Additional Sources for SKWD Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
SKWD Stock Overview
Market Cap in USD | 2,351m |
Sector | Financial Services |
Industry | Insurance - Property & Casualty |
GiC Sub-Industry | Property & Casualty Insurance |
IPO / Inception | 2023-01-13 |
SKWD Stock Ratings
Growth Rating | 65.8 |
Fundamental | 82.8 |
Dividend Rating | 0.0 |
Rel. Strength | 36.7 |
Analysts | 3.83 of 5 |
Fair Price Momentum | 74.07 USD |
Fair Price DCF | 161.12 USD |
SKWD Dividends
Currently no dividends paidSKWD Growth Ratios
Growth Correlation 3m | 83.8% |
Growth Correlation 12m | 89.4% |
Growth Correlation 5y | 98.1% |
CAGR 5y | 75.68% |
CAGR/Max DD 5y | 3.24 |
Sharpe Ratio 12m | 2.63 |
Alpha | 61.80 |
Beta | 0.558 |
Volatility | 38.12% |
Current Volume | 305.9k |
Average Volume 20d | 288.8k |
As of June 15, 2025, the stock is trading at USD 58.60 with a total of 305,900 shares traded.
Over the past week, the price has changed by -6.16%, over one month by -1.92%, over three months by +23.76% and over the past year by +70.05%.
Yes, based on ValueRay´s Fundamental Analyses, Skyward Specialty Insurance (NASDAQ:SKWD) is currently (June 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 82.80 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SKWD is around 74.07 USD . This means that SKWD is currently undervalued and has a potential upside of +26.4% (Margin of Safety).
Skyward Specialty Insurance has received a consensus analysts rating of 3.83. Therefor, it is recommend to buy SKWD.
- Strong Buy: 3
- Buy: 4
- Hold: 5
- Sell: 0
- Strong Sell: 0
According to our own proprietary Forecast Model, SKWD Skyward Specialty Insurance will be worth about 82.7 in June 2026. The stock is currently trading at 58.60. This means that the stock has a potential upside of +41.14%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 62.3 | 6.4% |
Analysts Target Price | 56.6 | -3.5% |
ValueRay Target Price | 82.7 | 41.1% |